AlphaYouVH
Schedule 13D filing
Venrock Healthcare Capital Partners III, L.P. disclosed a 9.9% stake in Korsana Biosciences, Inc. (KRSA)
Venrock Healthcare Capital Partners III, L.P. reported owning 9.9% of Korsana Biosciences, Inc. (KRSA) (4,552,277 shares) in a Schedule 13D filed Sep 15, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 15, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.